Back to ARWR
GOLDMAN SACHS GROUP INC → ARWR
GOLDMAN SACHS GROUP INC ARWR Position History
Arrowhead Pharmaceuticals, Inc. • Healthcare
Quarters held
22
Latest value
$591K
Q2 2026
Peak value
$80.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $24.7M |
| Q2 2025 | $1.3M |
| Q2 2025 | $8.7M |
| Q3 2025 | $47.1M |
| Q3 2025 | $14.1M |
| Q3 2025 | $1.7M |
| Q4 2025 | $326K |
| Q4 2025 | $30.5M |
| Q4 2025 | $80.5M |
| Q4 2025 | $664K |
| Q4 2025 | $664K |
| Q4 2025 | $80.5M |
| Q4 2025 | $664K |
| Q4 2025 | $664K |
| Q4 2025 | $30.5M |
| Q4 2025 | $326K |
| Q1 2026 | $76.2M |
| Q1 2026 | $32.5M |
| Q1 2026 | $383K |
| Q2 2026 | $55.2M |
| Q2 2026 | $37.9M |
| Q2 2026 | $591K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $591K | 7.3K | — | — |
| Q2 2026 | $37.9M | 465.3K | — | — |
| Q2 2026 | $55.2M | 677.5K | — | — |
| Q1 2026 | $383K | 6.1K | — | — |
| Q1 2026 | $32.5M | 518.9K | — | — |
| Q1 2026 | $76.2M | 1.21M | — | — |
| Q4 2025 | $326K | 4.9K | — | — |
| Q4 2025 | $30.5M | 459.9K | — | — |
| Q4 2025 | $664K | 10.0K | — | — |
| Q4 2025 | $664K | 10.0K | — | — |
| Q4 2025 | $80.5M | 1.21M | — | — |
| Q4 2025 | $664K | 10.0K | — | — |
| Q4 2025 | $664K | 10.0K | — | — |
| Q4 2025 | $80.5M | 1.21M | — | — |
| Q4 2025 | $30.5M | 459.9K | — | — |
| Q4 2025 | $326K | 4.9K | — | — |
| Q3 2025 | $1.7M | 49.7K | — | — |
| Q3 2025 | $14.1M | 409.7K | — | — |
| Q3 2025 | $47.1M | 1.36M | — | — |
| Q2 2025 | $8.7M | 549.3K | — | — |
| Q2 2025 | $1.3M | 81.3K | — | — |
| Q2 2025 | $24.7M | 1.57M | — | — |
Other funds holding ARWR
$464.2M
$464.2M
$407.3M
$259.8M
$108.9M